Lv31
340 积分 2024-08-18 加入
Interferon alfa-2a versus combination therapy with interferon alfa-2a, interleukin-2, and fluorouracil in patients with untreated metastatic renal cell carcinoma (MRC RE04/EORTC GU 30012): an open-label randomised trial
2个月前
已采纳
Accuracy of Interpretation of Preparticipation Screening Electrocardiograms
2个月前
已采纳
Mechanisms underlying aflatoxin-associated mutagenesis – Implications in carcinogenesis
2个月前
已采纳
皖公网安备34019202002308
